The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Recent developments in genomic analysis and advances in bioinformatics have enabled the adoption of more personalized treatment approaches, such as neoantigen targeted therapies. Cancer neoantigens is a term used to refer to a subset of antigens encoded by tumor-specific, mutated genes, which have not previously been recognized by the host’s immune system.
The global Neoantigen Targeted Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Neoantigen Targeted Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Neoantigen Targeted Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Neoantigen Targeted Therapies in Medical Research Institution is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Neoantigen Targeted Therapies include Bavarian Nordic, Genocea Biosciences, Gradalis, Immunicum, Immunovative Therapies, Iovance Biotherapeutics, MediGene and Neon Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Neoantigen Targeted Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neoantigen Targeted Therapies.
Report Scope
The Neoantigen Targeted Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neoantigen Targeted Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neoantigen Targeted Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Bavarian Nordic
- Genocea Biosciences
- Gradalis
- Immunicum
- Immunovative Therapies
- Iovance Biotherapeutics
- MediGene
- Neon Therapeutics
Segment by Type
- Monotherapy
- Combination Therapy
Segment by Application
- Medical Research Institution
- Hospital and Clinic
- Other
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neoantigen Targeted Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neoantigen Targeted Therapies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Neoantigen Targeted Therapies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Research Institution
1.3.3 Hospital and Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neoantigen Targeted Therapies Market Perspective (2019-2030)
2.2 Neoantigen Targeted Therapies Growth Trends by Region
2.2.1 Global Neoantigen Targeted Therapies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neoantigen Targeted Therapies Historic Market Size by Region (2019-2024)
2.2.3 Neoantigen Targeted Therapies Forecasted Market Size by Region (2025-2030)
2.3 Neoantigen Targeted Therapies Market Dynamics
2.3.1 Neoantigen Targeted Therapies Industry Trends
2.3.2 Neoantigen Targeted Therapies Market Drivers
2.3.3 Neoantigen Targeted Therapies Market Challenges
2.3.4 Neoantigen Targeted Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neoantigen Targeted Therapies Players by Revenue
3.1.1 Global Top Neoantigen Targeted Therapies Players by Revenue (2019-2024)
3.1.2 Global Neoantigen Targeted Therapies Revenue Market Share by Players (2019-2024)
3.2 Global Neoantigen Targeted Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neoantigen Targeted Therapies Revenue
3.4 Global Neoantigen Targeted Therapies Market Concentration Ratio
3.4.1 Global Neoantigen Targeted Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neoantigen Targeted Therapies Revenue in 2023
3.5 Neoantigen Targeted Therapies Key Players Head office and Area Served
3.6 Key Players Neoantigen Targeted Therapies Product Solution and Service
3.7 Date of Enter into Neoantigen Targeted Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neoantigen Targeted Therapies Breakdown Data by Type
4.1 Global Neoantigen Targeted Therapies Historic Market Size by Type (2019-2024)
4.2 Global Neoantigen Targeted Therapies Forecasted Market Size by Type (2025-2030)
5 Neoantigen Targeted Therapies Breakdown Data by Application
5.1 Global Neoantigen Targeted Therapies Historic Market Size by Application (2019-2024)
5.2 Global Neoantigen Targeted Therapies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neoantigen Targeted Therapies Market Size (2019-2030)
6.2 North America Neoantigen Targeted Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neoantigen Targeted Therapies Market Size by Country (2019-2024)
6.4 North America Neoantigen Targeted Therapies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neoantigen Targeted Therapies Market Size (2019-2030)
7.2 Europe Neoantigen Targeted Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neoantigen Targeted Therapies Market Size by Country (2019-2024)
7.4 Europe Neoantigen Targeted Therapies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neoantigen Targeted Therapies Market Size (2019-2030)
8.2 Asia-Pacific Neoantigen Targeted Therapies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neoantigen Targeted Therapies Market Size by Region (2019-2024)
8.4 Asia-Pacific Neoantigen Targeted Therapies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neoantigen Targeted Therapies Market Size (2019-2030)
9.2 Latin America Neoantigen Targeted Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neoantigen Targeted Therapies Market Size by Country (2019-2024)
9.4 Latin America Neoantigen Targeted Therapies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neoantigen Targeted Therapies Market Size (2019-2030)
10.2 Middle East & Africa Neoantigen Targeted Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neoantigen Targeted Therapies Market Size by Country (2019-2024)
10.4 Middle East & Africa Neoantigen Targeted Therapies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bavarian Nordic
11.1.1 Bavarian Nordic Company Detail
11.1.2 Bavarian Nordic Business Overview
11.1.3 Bavarian Nordic Neoantigen Targeted Therapies Introduction
11.1.4 Bavarian Nordic Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.1.5 Bavarian Nordic Recent Development
11.2 Genocea Biosciences
11.2.1 Genocea Biosciences Company Detail
11.2.2 Genocea Biosciences Business Overview
11.2.3 Genocea Biosciences Neoantigen Targeted Therapies Introduction
11.2.4 Genocea Biosciences Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.2.5 Genocea Biosciences Recent Development
11.3 Gradalis
11.3.1 Gradalis Company Detail
11.3.2 Gradalis Business Overview
11.3.3 Gradalis Neoantigen Targeted Therapies Introduction
11.3.4 Gradalis Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.3.5 Gradalis Recent Development
11.4 Immunicum
11.4.1 Immunicum Company Detail
11.4.2 Immunicum Business Overview
11.4.3 Immunicum Neoantigen Targeted Therapies Introduction
11.4.4 Immunicum Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.4.5 Immunicum Recent Development
11.5 Immunovative Therapies
11.5.1 Immunovative Therapies Company Detail
11.5.2 Immunovative Therapies Business Overview
11.5.3 Immunovative Therapies Neoantigen Targeted Therapies Introduction
11.5.4 Immunovative Therapies Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.5.5 Immunovative Therapies Recent Development
11.6 Iovance Biotherapeutics
11.6.1 Iovance Biotherapeutics Company Detail
11.6.2 Iovance Biotherapeutics Business Overview
11.6.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Introduction
11.6.4 Iovance Biotherapeutics Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.6.5 Iovance Biotherapeutics Recent Development
11.7 MediGene
11.7.1 MediGene Company Detail
11.7.2 MediGene Business Overview
11.7.3 MediGene Neoantigen Targeted Therapies Introduction
11.7.4 MediGene Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.7.5 MediGene Recent Development
11.8 Neon Therapeutics
11.8.1 Neon Therapeutics Company Detail
11.8.2 Neon Therapeutics Business Overview
11.8.3 Neon Therapeutics Neoantigen Targeted Therapies Introduction
11.8.4 Neon Therapeutics Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.8.5 Neon Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
